Only one in five U.S. pancreatic cancer patients get this key blood test at diagnosis

Only one in five U.S. pancreatic cancer patients receive a widely available, inexpensive blood test at diagnosis that can help predict whether they are likely to have a better or worse outcome than average and guide treatment accordingly, a new study shows.

from Today's Healthcare News -- ScienceDaily http://ift.tt/1H3VwB1